Document Detail


Pregnancy and diabetes management: advances and controversies.
MedLine Citation:
PMID:  21148303     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: The treatment of diabetes in pregnancy has potentially far-reaching benefits for both pregnant women with diabetes and their children and may provide a cost-effective approach to the prevention of obesity, type 2 diabetes mellitus, and metabolic syndrome. Early and accurate diagnosis of diabetes in pregnancy is necessary for optimizing maternal and fetal outcomes.
CONTENT: Optimal control of diabetes in pregnancy requires achieving normoglycemia at all stages of a woman's pregnancy, including preconception and the postpartum period. In this review we focus on new universal guidelines for the screening and diagnosis of diabetes in pregnancy, including the 75-g oral glucose tolerance test, as well as the controversy surrounding the guidelines. We review the best diagnostic and treatment strategies for the pregestational and intrapartum periods, labor and delivery, and the postpartum period, and discuss management algorithms as well as the safety and efficacy of diabetic medications for use in pregnancy.
SUMMARY: Global guidelines for screening, diagnosis, and classification have been established, and offer the potential to stop the cycle of diabetes and obesity caused by hyperglycemia in pregnancy. Normoglycemia is the goal in all aspects of pregnancy and offers the benefits of decreased short-term and long-term complications of diabetes.
Authors:
Kristin Castorino; Lois Jovanovic
Related Documents :
21275913 - Fear of childbirth, women's preference for cesarean section and childhood abuse: a long...
21308843 - Appearance of the fetal posterior fossa at 11+3 to 13+6 gestational weeks in transabdom...
7108313 - Lipid peroxidation and its protective mechanism during developmental stage in rat.
Publication Detail:
Type:  Journal Article     Date:  2010-12-09
Journal Detail:
Title:  Clinical chemistry     Volume:  57     ISSN:  1530-8561     ISO Abbreviation:  Clin. Chem.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  221-30     Citation Subset:  IM    
Affiliation:
Sansum Diabetes Research Institute, Santa Barbara, CA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sequence analysis of CYP21A1P in a German population to aid in the molecular biological diagnosis of...
Next Document:  Status of Hemoglobin A1c Measurement and Goals for Improvement: From Chaos to Order for Improving Di...